针对动脉样硬化的炎症途径:探索治疗的新机会
Alessia d'Aiello1, Simone Filomia2, Mattia Brecciaroli2
1Department of Cardiovascular Sciences- CUORE, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Largo A. Gemelli 8, 00168, Rome, Italy.
Current atherosclerosis reports
|October 15, 2024
概括
动脉样性心血管疾病 (ACVD) 涉及免疫机制. 抗炎疗法,如CANTOS,降低心血管风险,突出了剩余风险降低的新目标.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样性心血管疾病 (ACVD) 是全球主要的死亡原因.
- 标准的风险因素管理会留下剩余的心血管风险.
- 动脉样硬化中的免疫路径提供了潜在的治疗点.
研究的目的:
- 审查ACVD免疫病原发生的分子机制.
- 讨论已批准的心血管治疗的抗炎作用.
- 检查ACVD的免疫调节疗法,并确定新的点.
主要方法:
- 在ACVD免疫病原发生中的分子机制的审查.
- 对心血管药物的类抗炎作用的分析.
- 对ACVD免疫调节疗法的证据评估.
主要成果:
- 在CANTOS试验中,通过抗炎疗法证明了心血管风险的降低.
- 常见的药物 (SGLT2i,PCSK9i) 显示出类型的抗炎作用.
- 新兴疗法针对炎症化合物 (IL-2,PTPN22,CD31) 来降低残留风险.
结论:
- 针对免疫机制对于解决残留ACVD风险至关重要.
- 精准医学方法可以识别新的治疗点和生物标志物.
- 进一步的临床和转化研究对于推进ACVD治疗至关重要.
相关概念视频
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Inflammation
53.0K
Overview
53.0K
Atherosclerosis I: Introduction
2
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2
Peripheral Artery Disease III: Interprofessional Care
3
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3
Atherosclerosis II: Clinical manifestations and prevention
2
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
2
Atherosclerosis IV: Nursing Management
2
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
2


